![Ronald J. Silberman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ronald J. Silberman
Direktor/Vorstandsmitglied bei Slingshot Biosciences, Inc.
Aktive Positionen von Ronald J. Silberman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Slingshot Biosciences, Inc.
![]() Slingshot Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Ronald J. Silberman
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Slingshot Biosciences, Inc.
![]() Slingshot Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012. | Commercial Services |
- Börse
- Insiders
- Ronald J. Silberman
- Erfahrung